Pantoea agglomerans: an unusual inciting agent in peritonitis.
Ferrantino
M
M
Navaneethan
S D
SD
Sloand
J A
JA
D000583:Amikacin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002442:Ceftazidime / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D020636:Pantoea / Q000187:drug effects* / Q000302:isolation & purification; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome; D014947:Wounds and Injuries / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000583:Amikacin; D002442:Ceftazidime